NovaBay Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
NovaBay Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 111 %, a 47.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 111 -99.7 -47.4% Sep 30, 2024
Q2 2024 129 -104 -44.5% Jun 30, 2024
Q1 2024 160 -97.2 -37.8% Mar 31, 2024
Q4 2023 189 -78.8 -29.5% Dec 31, 2023
Q3 2023 210 -82.7 -28.2% Sep 30, 2023
Q2 2023 233 -82.5 -26.1% Jun 30, 2023
Q1 2023 257 -113 -30.5% Mar 31, 2023
Q4 2022 267 -162 -37.7% Dec 31, 2022
Q3 2022 293 -169 -36.6% Sep 30, 2022
Q2 2022 316 -181 -36.4% Jun 30, 2022
Q1 2022 370 -48.4 -11.6% Mar 31, 2022
Q4 2021 429 +109 +34% Dec 31, 2021
Q3 2021 462 +218 +89% Sep 30, 2021
Q2 2021 497 +305 +159% Jun 30, 2021
Q1 2021 418 +239 +133% Mar 31, 2021
Q4 2020 320 +144 +81.8% Dec 31, 2020
Q3 2020 245 +55.2 +29.2% Sep 30, 2020
Q2 2020 192 -13 -6.35% Jun 30, 2020
Q1 2020 179 -50.2 -21.9% Mar 31, 2020
Q4 2019 176 -133 -43% Dec 31, 2019
Q3 2019 189 -98.3 -34.2% Sep 30, 2019
Q2 2019 205 -52.5 -20.4% Jun 30, 2019
Q1 2019 230 -5.11 -2.18% Mar 31, 2019
Q4 2018 309 +94 +43.7% Dec 31, 2018
Q3 2018 288 +35.8 +14.2% Sep 30, 2018
Q2 2018 257 -43.4 -14.4% Jun 30, 2018
Q1 2018 235 -46.4 -16.5% Mar 31, 2018
Q4 2017 215 -28.5 -11.7% Dec 31, 2017
Q3 2017 252 +72.4 +40.3% Sep 30, 2017
Q2 2017 301 +174 +138% Jun 30, 2017
Q1 2017 281 +122 +76.9% Mar 31, 2017
Q4 2016 243 +61.3 +33.6% Dec 31, 2016
Q3 2016 180 -36.5 -16.9% Sep 30, 2016
Q2 2016 126 -158 -55.6% Jun 30, 2016
Q1 2016 159 -173 -52.1% Mar 31, 2016
Q4 2015 182 -284 -61% Dec 31, 2015
Q3 2015 216 -314 -59.2% Sep 30, 2015
Q2 2015 285 -221 -43.7% Jun 30, 2015
Q1 2015 332 -133 -28.6% Mar 31, 2015
Q4 2014 466 +24.7 +5.59% Dec 31, 2014
Q3 2014 530 +40.4 +8.24% Sep 30, 2014
Q2 2014 505 +45.7 +9.93% Jun 30, 2014
Q1 2014 465 +45.9 +11% Mar 31, 2014
Q4 2013 442 +49.4 +12.6% Dec 31, 2013
Q3 2013 490 +115 +30.7% Sep 30, 2013
Q2 2013 460 +52.2 +12.8% Jun 30, 2013
Q1 2013 419 -8.32 -1.95% Mar 31, 2013
Q4 2012 392 Dec 31, 2012
Q3 2012 375 Sep 30, 2012
Q2 2012 408 Jun 30, 2012
Q1 2012 427 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.